Emmanouil Brilakis, MD
Interventional Cardiology · Minneapolis, MNNPI 1194781674
Payments from drug & device makers
Across 566 payments — averaging $3905.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$701K
- GE HealthCare$555K
- Boston Scientific$223K
- Medtronic$182K
- Abbott$162K
- Amgen$78K
- plus $311K from 27 others
What the payments were for
- Consulting fees$264,63948%
- Speaking & faculty fees$235,24643%
- Travel & lodging$29,9915%
- Food & beverage$17,6293%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 12 | $700,947 |
| GE HealthCare | 28 | $554,596 |
| Boston Scientific | 43 | $222,546 |
| Medtronic(2 entities) | 157 | $181,655 |
| Abbott | 144 | $161,649 |
| Amgen | 14 | $78,151 |
| Cardiovascular Systems Inc. | 38 | $56,745 |
| Siemens Medical Solutions USA, Inc. | 6 | $51,068 |
| Arrow International, Inc. | 4 | $49,522 |
| Biotronik Inc. | 42 | $44,389 |
| M.a. Med Alliance S.A. | 8 | $27,154 |
| Shockwave Medical, Inc | 3 | $19,232 |
| Teleflex LLC | 15 | $16,075 |
| B. Braun Interventional Systems Inc. | 1 | $10,125 |
| Opsens Inc. | 5 | $7,932 |
| Cordis US CORP. | 6 | $7,296 |
| Recor Medical Inc | 6 | $4,348 |
| Vascular Solutions, Inc. | 1 | $2,475 |
| Asahi Intecc USA, Inc. | 4 | $2,344 |
| Magenta Medical Inc | 4 | $2,250 |
| Arrow Interventional, Inc. | 1 | $2,250 |
| Terumo Medical Corporation | 3 | $2,150 |
| Medalliance LLC | 1 | $1,972 |
| Cardiva Medical, Inc. | 1 | $1,500 |
| Heartflow, Inc. | 4 | $863 |
| Abiomed | 6 | $568 |
| Reflow Medical Inc | 1 | $177 |
| Cleerly, Inc. | 2 | $129 |
| Philips North America LLC | 1 | $119 |
| Biolife, L.L.C. | 1 | $110 |
| Getinge USA Sales, LLC | 1 | $51 |
| Cathworks, Inc. | 1 | $29 |
| Chiesi USA, Inc. | 2 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$99,107
- ONYX FRONTIER$53,756
- Resolute$47,875
- Xience V coronary stent system$41,053
- Diamondback Coronary$29,220
- Coronary Orbital Atherectomy System$28,828
- GENERAL VASCULAR ACCESS$23,480
- VISIPAQUE$13,750
- RESOLUTE ONYX$12,758
- DRAGONFLY OPSTAR$12,205
- SYMPLICITY G3$11,944
- Repatha$11,485
- GUIDELINER$9,575
- GENERAL - THERAPIES$8,452
- cardio$6,536
- SavvyWire$6,300
- Diamondback Peripheral$6,210
- Interventional Products$4,725
- Paradise Ultrasound Renal Denervation System$4,315
- GUIDELINER V3 CATHETER$4,050
How this compares
$2,210,441 in reported general payments places this provider in the 95th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $94,362 |
| Repatha SureclickEvolocumab | 38 | $31,062 |
| OzempicSemaglutide | 14 | $13,338 |
| XareltoRivaroxaban | 13 | $11,290 |
| ClopidogrelClopidogrel Bisulfate | 133 | $2,250 |
| Ranolazine ErRanolazine | 13 | $2,112 |
| Metoprolol Succinate | 84 | $2,084 |
| Atorvastatin Calcium | 102 | $1,974 |
| Rosuvastatin Calcium | 80 | $1,451 |
| Losartan Potassium | 94 | $1,447 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 57 | $1,165 |
| Amlodipine Besylate | 93 | $964 |
| Ezetimibe | 51 | $688 |
| Carvedilol | 66 | $625 |
| Prasugrel Hcl | 22 | $572 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Minneapolis
- Yale WangMinneapolis$725K
- Ivan ChavezMinneapolis$539K
- Wesley PedersenMinneapolis$517K
- Martin BurkeMinneapolis$389K
- Jay TraverseMinneapolis$324K
- Konstantinos VoudrisMinneapolis$202K
- Michael ManolesMinneapolis$201K
- Alok SharmaMinneapolis$182K
- Robert WilsonMinneapolis$176K
- Anil PouloseMinneapolis$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.